Three regulatory veterinarians said Jan. 12 they support recent action by the Association of Racing Commissioners International to adopt a model rule on compounded drugs used in horse racing.
RCI said Jan. 5 it is taking steps to ensure regulatory agencies have adequate authority to sanction licensees who violate existing federal restrictions limiting the use of illegally compounded medications.
The Racing Medication and Testing Consortium believes the majority of racing jurisdictions will have a substantial portion of the National Uniform Medication Program in place by year's end.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
The United States District Court in the Northern District of New York has dismissed a wrongful-death lawsuit filed by a group of Thoroughbred owners against New Jersey-based Wedgewood Pharmacy in September 2005.
- By Tom LaMarra
The American Association of Equine Practitioners, in an effort to educate members, has issued guidelines for the responsible use of compounded medications by veterinarians.
Most Popular Stories
- Pletcher Breezes Four Kentucky Derby Hopefuls
- Classic Empire a Pro in Four-Furlong Move
- Espinoza Wins First Race After HOF Announcement
- Girvin Battling Quarter Crack, KY Derby Not Ruled Out
- Sano Star Gunnevera Goes Easy Five Furlongs
- Blinkers Likely for Practical Joke in Kentucky Derby
- O'Neill Confident After Irap's Mile Work
- Vexatious Stands Out in Oaks Move
- BloodHorse.com Launches BackTrack Channel
- Quiet Business Wins Bewitch on Keeneland's Closing Day